Lifecore Biomedical
LFCR
LFCR
85 hedge funds and large institutions have $220M invested in Lifecore Biomedical in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 28 increasing their positions, 32 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% less capital invested
Capital invested by funds: $252M → $220M (-$32.1M)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $71K
Holders
85
Holding in Top 10
5
Calls
–
Puts
$71K
Top Buyers
| 1 | +$3.67M | |
| 2 | +$2.95M | |
| 3 | +$717K | |
| 4 |
Boston Partners
Boston,
Massachusetts
|
+$141K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$137K |
Top Sellers
| 1 | -$6.32M | |
| 2 | -$1.7M | |
| 3 | -$951K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$869K |
| 5 |
BlackRock
New York
|
-$843K |